Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MAZYAR SHADMAN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1750554077
CMS profile
499030
Location
SEATTLE, WA

General Payments · PY2018–2024

$187,880.39

  • Reported across 201 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$44,061.76

35 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $41,061.00 13
Food and Beverage $1,697.60 19
Travel and Lodging $1,303.16 3

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ADC Therapeutics America, Inc. $14,373.24 9
E.R. Squibb & Sons, L.L.C. $11,626.00 2
Acerta Pharma LLC $4,217.74 3
BeiGene USA, Inc. $3,854.34 2
PFIZER INC. $3,358.18 2
ABBVIE INC. $2,997.52 11
Janssen Global Services, LLC $1,635.00 1
Gilead Sciences, Inc. $1,450.00 1
Genmab U.S., Inc. $267.70 2
Celgene Corporation $149.78 1
Eli Lilly and Company $132.26 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $4,035.24 10
PY2019 $18,280.84 35
PY2020 $24,271.80 19
PY2021 $34,862.77 26
PY2022 $29,680.88 36
PY2023 $32,687.10 40
PY2024 $44,061.76 35

Payment records · PY2024 (35)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $1,375.00 01/08/2024 Consulting Fee Undisputed 01/23/2026 1106061012 CMS
ABBVIE INC. $69.22 03/22/2024 Food and Beverage Undisputed 01/23/2026 1106061014 CMS
ABBVIE INC. $54.26 05/04/2024 Food and Beverage Undisputed 01/23/2026 1106061016 CMS
ABBVIE INC. $275.00 07/31/2024 Consulting Fee Undisputed 01/23/2026 1106061018 CMS
ABBVIE INC. $275.00 08/16/2024 Consulting Fee Undisputed 01/23/2026 1106061020 CMS
ABBVIE INC. $450.00 08/20/2024 Consulting Fee Undisputed 01/23/2026 1106061022 CMS
ABBVIE INC. $275.00 11/15/2024 Consulting Fee Undisputed 01/23/2026 1106061024 CMS
ABBVIE INC. $18.99 12/05/2024 Food and Beverage Undisputed 01/23/2026 1106061026 CMS
ABBVIE INC. $141.37 12/05/2024 Food and Beverage Undisputed 01/23/2026 1106061028 CMS
ABBVIE INC. $13.68 12/07/2024 Food and Beverage Undisputed 01/23/2026 1106061030 CMS
ABBVIE INC. $50.00 12/07/2024 Food and Beverage Undisputed 01/23/2026 1106061032 CMS
ADC Therapeutics America, Inc. $118.08 03/29/2024 Food and Beverage Undisputed 01/23/2026 1121186768 CMS
ADC Therapeutics America, Inc. $906.22 09/09/2024 Travel and Lodging Undisputed 01/23/2026 1121186864 CMS
ADC Therapeutics America, Inc. $322.94 09/20/2024 Travel and Lodging Undisputed 01/23/2026 1121186852 CMS
ADC Therapeutics America, Inc. $140.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1121186854 CMS
ADC Therapeutics America, Inc. $72.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1121186856 CMS
ADC Therapeutics America, Inc. $40.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1121186858 CMS
ADC Therapeutics America, Inc. $100.00 09/20/2024 Food and Beverage Undisputed 01/23/2026 1121186860 CMS
ADC Therapeutics America, Inc. $12,600.00 10/31/2024 Consulting Fee Undisputed 01/23/2026 1121186882 CMS
ADC Therapeutics America, Inc. $74.00 12/10/2024 Travel and Lodging Undisputed 01/23/2026 1121186862 CMS
AstraZeneca Pharmaceuticals LP $4,110.00 06/07/2024 Consulting Fee Undisputed 01/23/2026 1110536416 CMS
AstraZeneca Pharmaceuticals LP $47.74 07/27/2024 Food and Beverage Undisputed 01/23/2026 1110539235 CMS
AstraZeneca Pharmaceuticals LP $60.00 12/09/2024 Food and Beverage Undisputed 01/23/2026 1110549876 CMS
BeiGene USA, Inc. $3,750.00 04/04/2024 Consulting Fee Undisputed 01/23/2026 1120855816 CMS
BeiGene USA, Inc. $104.34 10/18/2024 Food and Beverage Undisputed 01/23/2026 1120855814 CMS
Celgene Corporation $149.78 05/07/2024 Food and Beverage Undisputed 01/23/2026 1101148358 CMS
E.R. Squibb & Sons, L.L.C. $2,076.00 04/01/2024 Consulting Fee Undisputed 01/23/2026 1101507040 CMS
E.R. Squibb & Sons, L.L.C. $9,550.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 1101507245 CMS
Eli Lilly and Company $132.26 06/01/2024 Food and Beverage Undisputed 01/23/2026 1135180436 CMS
Genmab U.S., Inc. $157.67 04/05/2024 Food and Beverage Undisputed 01/23/2026 1126829650 CMS
Genmab U.S., Inc. $110.03 06/02/2024 Food and Beverage Undisputed 01/23/2026 1126829648 CMS
Gilead Sciences, Inc. $1,450.00 12/13/2024 Consulting Fee Undisputed 01/23/2026 1133600385 CMS
Janssen Global Services, LLC $1,635.00 10/18/2024 Consulting Fee Undisputed 01/23/2026 1077592691 CMS
PFIZER INC. $118.18 12/09/2024 Food and Beverage Undisputed 01/23/2026 1131382520 CMS
PFIZER INC. $3,240.00 12/31/2024 Consulting Fee Undisputed 01/23/2026 1131394908 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.